vs
Avantor, Inc.（AVTR）与RYDER SYSTEM INC（R）财务数据对比。点击上方公司名可切换其他公司
RYDER SYSTEM INC的季度营收约是Avantor, Inc.的1.9倍（$3.1B vs $1.7B），Avantor, Inc.净利率更高（3.1% vs 3.0%，领先0.2%），RYDER SYSTEM INC同比增速更快（1.0% vs -1.4%），RYDER SYSTEM INC自由现金流更多（$273.0M vs $117.2M），过去两年Avantor, Inc.的营收复合增速更高（-0.5% vs -0.9%）
Avantor是一家总部位于美国宾夕法尼亚州拉德诺的生物技术、化工及制药领域企业，前身为1904年成立的J.T. Baker，2010年正式更名，2019年在纽约证券交易所挂牌上市，股票代码为AVTR，为全球生命科学、医疗健康等行业客户提供核心产品与服务。
Ryder System Inc.是美国专业运输物流服务商，总部位于佛罗里达州科勒尔盖布尔斯，业务覆盖美国及英国，核心业务包含卡车租赁、车队管理、供应链及运输管理，同时提供车辆维保、二手车销售、专业司机派遣、电商履约与最后一公里配送等多元服务。
AVTR vs R — 直观对比
营收规模更大
R
是对方的1.9倍
$1.7B
营收增速更快
R
高出2.4%
-1.4%
净利率更高
AVTR
高出0.2%
3.0%
自由现金流更多
R
多$155.8M
$117.2M
两年增速更快
AVTR
近两年复合增速
-0.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $3.1B |
| 净利润 | $52.4M | $93.0M |
| 毛利率 | 31.5% | — |
| 营业利润率 | 7.6% | — |
| 净利率 | 3.1% | 3.0% |
| 营收同比 | -1.4% | 1.0% |
| 净利润同比 | -89.5% | -5.1% |
| 每股收益（稀释后） | $0.08 | $2.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVTRR
| Q1 26 | — | $3.1B | ||
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.7B | $3.2B | ||
| Q1 25 | $1.6B | $3.1B | ||
| Q4 24 | $1.7B | $3.2B | ||
| Q3 24 | $1.7B | $3.2B | ||
| Q2 24 | $1.7B | $3.2B |
净利润AVTRR
| Q1 26 | — | $93.0M | ||
| Q4 25 | $52.4M | $132.0M | ||
| Q3 25 | $-711.8M | $138.0M | ||
| Q2 25 | $64.7M | $131.0M | ||
| Q1 25 | $64.5M | $98.0M | ||
| Q4 24 | $500.4M | $135.0M | ||
| Q3 24 | $57.8M | $142.0M | ||
| Q2 24 | $92.9M | $127.0M |
毛利率AVTRR
| Q1 26 | — | — | ||
| Q4 25 | 31.5% | — | ||
| Q3 25 | 32.4% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 33.8% | — | ||
| Q4 24 | 33.4% | — | ||
| Q3 24 | 32.9% | — | ||
| Q2 24 | 34.1% | — |
营业利润率AVTRR
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 5.6% | ||
| Q3 25 | -40.0% | 6.0% | ||
| Q2 25 | 7.7% | 5.8% | ||
| Q1 25 | 9.3% | 4.3% | ||
| Q4 24 | 37.8% | 5.7% | ||
| Q3 24 | 7.3% | 5.9% | ||
| Q2 24 | 10.3% | 5.6% |
净利率AVTRR
| Q1 26 | — | 3.0% | ||
| Q4 25 | 3.1% | 4.2% | ||
| Q3 25 | -43.8% | 4.4% | ||
| Q2 25 | 3.8% | 4.1% | ||
| Q1 25 | 4.1% | 3.1% | ||
| Q4 24 | 29.7% | 4.2% | ||
| Q3 24 | 3.4% | 4.5% | ||
| Q2 24 | 5.5% | 4.0% |
每股收益（稀释后）AVTRR
| Q1 26 | — | $2.34 | ||
| Q4 25 | $0.08 | $3.22 | ||
| Q3 25 | $-1.04 | $3.32 | ||
| Q2 25 | $0.09 | $3.13 | ||
| Q1 25 | $0.09 | $2.27 | ||
| Q4 24 | $0.73 | $3.09 | ||
| Q3 24 | $0.08 | $3.24 | ||
| Q2 24 | $0.14 | $2.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $365.4M | $182.0M |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $5.6B | $2.9B |
| 总资产 | $11.8B | — |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资AVTRR
| Q1 26 | — | $182.0M | ||
| Q4 25 | $365.4M | $198.0M | ||
| Q3 25 | $251.9M | $189.0M | ||
| Q2 25 | $449.4M | $180.0M | ||
| Q1 25 | $315.7M | $151.0M | ||
| Q4 24 | $261.9M | $154.0M | ||
| Q3 24 | $285.3M | $162.0M | ||
| Q2 24 | $272.6M | $164.0M |
总债务AVTRR
| Q1 26 | — | — | ||
| Q4 25 | $3.9B | $6.8B | ||
| Q3 25 | $3.9B | $7.3B | ||
| Q2 25 | $4.2B | $7.0B | ||
| Q1 25 | $4.1B | $6.7B | ||
| Q4 24 | $4.1B | $6.7B | ||
| Q3 24 | $4.9B | $6.6B | ||
| Q2 24 | $5.1B | $6.5B |
股东权益AVTRR
| Q1 26 | — | $2.9B | ||
| Q4 25 | $5.6B | $3.1B | ||
| Q3 25 | $5.6B | $3.1B | ||
| Q2 25 | $6.3B | $3.1B | ||
| Q1 25 | $6.1B | $3.0B | ||
| Q4 24 | $6.0B | $3.1B | ||
| Q3 24 | $5.6B | $3.1B | ||
| Q2 24 | $5.4B | $3.1B |
总资产AVTRR
| Q1 26 | — | — | ||
| Q4 25 | $11.8B | $16.4B | ||
| Q3 25 | $11.7B | $16.5B | ||
| Q2 25 | $12.8B | $16.5B | ||
| Q1 25 | $12.3B | $16.4B | ||
| Q4 24 | $12.1B | $16.7B | ||
| Q3 24 | $12.8B | $16.5B | ||
| Q2 24 | $12.7B | $16.4B |
负债/权益比AVTRR
| Q1 26 | — | — | ||
| Q4 25 | 0.71× | 2.24× | ||
| Q3 25 | 0.69× | 2.35× | ||
| Q2 25 | 0.67× | 2.27× | ||
| Q1 25 | 0.67× | 2.21× | ||
| Q4 24 | 0.68× | 2.14× | ||
| Q3 24 | 0.89× | 2.17× | ||
| Q2 24 | 0.94× | 2.09× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $152.7M | $583.0M |
| 自由现金流经营现金流 - 资本支出 | $117.2M | $273.0M |
| 自由现金流率自由现金流/营收 | 7.0% | 8.7% |
| 资本支出强度资本支出/营收 | 2.1% | 13.7% |
| 现金转化率经营现金流/净利润 | 2.91× | 6.27× |
| 过去12个月自由现金流最近4个季度 | $495.0M | $595.0M |
8季度趋势，按日历期对齐
经营现金流AVTRR
| Q1 26 | — | $583.0M | ||
| Q4 25 | $152.7M | $749.0M | ||
| Q3 25 | $207.4M | $442.0M | ||
| Q2 25 | $154.4M | $752.0M | ||
| Q1 25 | $109.3M | $651.0M | ||
| Q4 24 | $173.3M | $558.0M | ||
| Q3 24 | $244.8M | $629.0M | ||
| Q2 24 | $281.1M | $552.0M |
自由现金流AVTRR
| Q1 26 | — | $273.0M | ||
| Q4 25 | $117.2M | $344.0M | ||
| Q3 25 | $171.7M | $-85.0M | ||
| Q2 25 | $124.8M | $63.0M | ||
| Q1 25 | $81.3M | $137.0M | ||
| Q4 24 | $145.8M | $-201.0M | ||
| Q3 24 | $204.0M | $30.0M | ||
| Q2 24 | $235.3M | $-87.0M |
自由现金流率AVTRR
| Q1 26 | — | 8.7% | ||
| Q4 25 | 7.0% | 10.8% | ||
| Q3 25 | 10.6% | -2.7% | ||
| Q2 25 | 7.4% | 2.0% | ||
| Q1 25 | 5.1% | 4.4% | ||
| Q4 24 | 8.6% | -6.3% | ||
| Q3 24 | 11.9% | 0.9% | ||
| Q2 24 | 13.8% | -2.7% |
资本支出强度AVTRR
| Q1 26 | — | 13.7% | ||
| Q4 25 | 2.1% | 12.8% | ||
| Q3 25 | 2.2% | 16.6% | ||
| Q2 25 | 1.8% | 21.6% | ||
| Q1 25 | 1.8% | 16.4% | ||
| Q4 24 | 1.6% | 23.8% | ||
| Q3 24 | 2.4% | 18.9% | ||
| Q2 24 | 2.7% | 20.1% |
现金转化率AVTRR
| Q1 26 | — | 6.27× | ||
| Q4 25 | 2.91× | 5.67× | ||
| Q3 25 | — | 3.20× | ||
| Q2 25 | 2.39× | 5.74× | ||
| Q1 25 | 1.69× | 6.64× | ||
| Q4 24 | 0.35× | 4.13× | ||
| Q3 24 | 4.24× | 4.43× | ||
| Q2 24 | 3.03× | 4.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVTR
| Laboratory Solutions Segment | $1.1B | 67% |
| Bioscience Production Segment | $547.5M | 33% |
R
| Fleet Management Solutions | $1.5B | 47% |
| ChoiceLease | $878.0M | 28% |
| Dedicated Transportation Solutions | $553.0M | 18% |
| Commercial rental | $211.0M | 7% |
